Author Question: After seven half-lives of a drug, which of the following percentages of the medication or drug ... (Read 84 times)

cookcarl

  • Hero Member
  • *****
  • Posts: 539
After seven half-lives of a drug, which of the following percentages of the medication or drug remains in the plasma of the person taking that drug?
 
  a. less than 1
  b. 1.5
  c. 5
  d. 50

Question 2

During the assessment of a healthy older adult, which normal age-related changes in memory functioning should a nurse anticipate?
 
  A) Mild deterioration in short-term memory; no change in long-term memory
  B) Mild deterioration in short-term memory; mild deterioration in long-term memory
  C) No change in short-term memory; mild deterioration in long-term memory
  D) No change in short-term memory; no change in long-term memory



shoemake

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

A
After seven half-lives, less than 1 of the medication remains in the plasma. A drug's half-life is the time required for plasma concentrations of a drug to decrease to half of an initial value. After each successive half-life, half of the medication remains in the plasma that was there before. For instance, after the eighth half-life, less than 0.5 of the medication remains in the plasma, which is half of the medication in the plasma that was present after the seventh half-life

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library